Several small molecule inhibitors of BET have progressed into the clinic17, and protection against liver fibrosis as well as reversal of fibrotic progression has been reported in a chemically induced mouse model following BET inhibition14,18. This evidence concerns the gene DNER and Hepatic fibrosis.